Organigram Appoints New CEO to Drive Global Growth
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from OrganiGram Holdings ( (TSE:OGI) ) is now available.
On November 25, 2025, Organigram Global Inc. announced the appointment of James Yamanaka as its new Chief Executive Officer, effective January 15, 2026. Yamanaka, with a strong background in strategy and management from British American Tobacco, is expected to drive Organigram’s international growth and strengthen its position as a global leader in the cannabis industry. During the transition, Peter Amirault will serve as Executive Chair, overseeing daily operations.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ overall score reflects strong earnings performance and market position, offset by technical weakness and valuation concerns. The company’s financial performance shows potential, but cash flow management needs improvement. The positive sentiment from the earnings call suggests a promising long-term trajectory, despite current challenges.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a leading Canadian producer of cannabis, focusing on the recreational cannabis market. The company is known for its high-quality products, trusted brands, and commitment to industry-leading innovation.
Average Trading Volume: 183,695
Technical Sentiment Signal: Buy
Current Market Cap: C$296.9M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.
